This funding opportunity will launch later in 2022.
Our Expansion Award enables teams to add new approaches and directions to their current work — even ones that weren’t around when their study began — by providing a one time grant of $50,000. This small but mighty grant has a submission and award process that occurs in under two months’ time, springboarding these studies forward, faster.
Who Can Apply
Proposed projects must be led by Principal Investigator(s) (PIs) who hold doctoral degrees (e.g., PhD, MD, PsyD, or equivalent) and are listed as a PI on a SV-related grant funded through Dec 31, 2021.
What Science Fits
- Expansion of existing funded studies within the Single Ventricle (SV) research community, and
- Use, development, or acquisition of enabling tools or technologies in an existing study
Competitive applications must provide a credible and realistic discussion of how the award will expand the scope, expedite time to completion, or otherwise increase the scientific interest or impact of an existing project.
Acceptable examples of fund usage may include, and are not limited to:
- Sample preparation, data storage, or processing (e.g., for large scale sequencing, proteomic, or computational projects)
- Animal or iPSC model development
- Computational tool or software development
- Equipment acquisition (e.g., bioreactors, microscopes, 3D printers, computers)
- Specialized training for personnel (e.g., technique-specific training courses and associated travel/support, or travel for training or to conduct work in a collaborator’s lab)
Deadlines are subject to change at the discretion of Additional Ventures in response to nationally or globally relevant events, including the COVID-19 pandemic. Any date that falls on a weekend will default to the next Monday.
Previous Tools & Technology Cycles
In 2020, we funded 10 projects across 10 international universities for a total of $500,000. Work ranged from developing machine learning algorithms for splicing to the addition of novel single-cell ‘omics techniques to develop regulatory maps.
Later in 2022